Intuitive Surgical (NASDAQ:ISRG) Now Covered by CICC Research

CICC Research assumed coverage on shares of Intuitive Surgical (NASDAQ:ISRG) in a report issued on Monday. The brokerage issued a neutral rating and a $550.00 price objective on the medical equipment provider’s stock.

Several other research firms have also issued reports on ISRG. Evercore ISI raised their price target on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday. Robert W. Baird upped their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday. Finally, Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $573.48 on Monday. The stock has a market cap of $204.26 billion, a price-to-earnings ratio of 92.20, a P/E/G ratio of 5.19 and a beta of 1.39. The company has a 50 day moving average of $547.16 and a 200-day moving average of $505.21. Intuitive Surgical has a one year low of $364.17 and a one year high of $616.00.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,265 shares of company stock valued at $21,964,281. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

Large investors have recently modified their holdings of the business. AQR Capital Management LLC boosted its stake in shares of Intuitive Surgical by 12.6% in the 2nd quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock valued at $18,958,000 after purchasing an additional 4,775 shares in the last quarter. Creative Planning boosted its position in Intuitive Surgical by 9.8% in the second quarter. Creative Planning now owns 63,039 shares of the medical equipment provider’s stock valued at $28,043,000 after buying an additional 5,629 shares in the last quarter. NewEdge Advisors LLC grew its stake in shares of Intuitive Surgical by 8.2% during the second quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock worth $6,150,000 after buying an additional 1,044 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Intuitive Surgical by 2.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider’s stock worth $9,100,000 after buying an additional 411 shares in the last quarter. Finally, Wellington Wealth Strategies LLC. bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at $241,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.